Christopher Paul Simms
CIK: 0001877012
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FDMT
4D Molecular Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Simms Christopher Paul
Simms Christopher Paul (SEC CIK 0001877012) files insider reports with the SEC as Officer of 4D Molecular Therapeutics, Inc. (FDMT).
Signal8 holds 2 ownership filings by Simms Christopher Paul (1 Form 3, 1 Form 4), filed between Dec 19, 2025 and Mar 27, 2026. Those filings report 1 transaction, the latest on Mar 25, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Simms Christopher Paul's filings is in EMERYVILLE, CA.
Recent filings by Simms Christopher Paul
- Mar 25, 2026: Grant or award of FDMT derivative securities (Form 4, code A).
Other insiders filing for 4D Molecular Therapeutics, Inc. (FDMT)
- Bizily Scott, Chief Legal Officer
- Kirn David
- Tomasello Shawn, Director
- THEUER CHARLES, Director
- Miller-Rich Nancy, Director
- GRAY SUSANNAH, Director